Adjunctive Therapy in Community-Acquired Pneumonia

Despite potent antibiotics, community-acquired pneumonia (CAP) remains the most common cause of death from infection and the eighth overall leading cause of death in the United States. For this reason, adjunctive therapeutic measures directed at the host response rather than the pathogen are attractive. The immunomodulatory effects of macrolide antibiotics may play a significant role in management of severe CAP.

Publicado en Sin categoría |

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *